Divi's Laboratories Q2 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
8,500.00
0.00 (0.00%)
0.00 (0.00%)Volume12.64 K
Updated: Fri 14 Aug, 2026 | 15:57:11
NSE
8,477.00-23.00 (-0.27%)
-23.00 (-0.27%)Volume3.40 L
Updated: Fri 14 Aug, 2026 | 15:51:10
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Divi's Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,940.00 | 1,951.00 | 8.20% | 1,721.00 | 12.73% |
| Depreciation/ Amortization | 113.00 | 133.00 | 0.89% | 99.00 | 14.14% |
| Operating Income | 775.00 | 1,129.00 | 25.61% | 617.00 | 25.61% |
| Net Income | 689.00 | 902.00 | 26.42% | 510.00 | 35.10% |
| Other Operating Expenses Total | 400.00 | 424.00 | 3.90% | 349.00 | 14.61% |
| Net Income Before Taxes | 912.00 | 1,180.00 | 24.42% | 722.00 | 26.32% |
| Total Revenue | 2,715.00 | 3,080.00 | 12.66% | 2,338.00 | 16.12% |
| Selling/ General/ Admin Expenses Total | 354.00 | 408.00 | 4.12% | 304.00 | 16.45% |
| Diluted Normalized EPS | 25.97 | 33.95 | 26.28% | 19.20 | 35.26% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.